SES - Delayed Quote SGD

UG Healthcare Corporation Limited (8K7.SI)

Compare
0.1350 -0.0020 (-1.46%)
At close: 5:04 PM GMT+8
Loading Chart for 8K7.SI
DELL
  • Previous Close 0.1370
  • Open 0.1370
  • Bid 0.1360 x --
  • Ask 0.1370 x --
  • Day's Range 0.1350 - 0.1400
  • 52 Week Range 0.0860 - 0.2250
  • Volume 1,430,500
  • Avg. Volume 2,426,815
  • Market Cap (intraday) 84.217M
  • Beta (5Y Monthly) 0.79
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date Aug 20, 2024 - Aug 21, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Nov 17, 2022
  • 1y Target Est --

UG Healthcare Corporation Limited, an investment holding company, manufactures and sells disposable gloves. The company operates through three segments: Latex Examination Gloves, Nitrile Examination Gloves, and Other Ancillary Products. It distributes ancillary products, including surgical gloves, vinyl and cleanroom disposable gloves, face masks, and other medical disposables; manufactures rubber gloves; and provides business and management consultancy services. The company's products are used in medical and healthcare, food and beverage, industrial, research and development, and beauty sectors. It serves customers under the Unigloves brand name in Europe, South America, Africa, China, and The United States of America. The company was founded in 1989 and is based in Singapore.

www.ughealthcarecorporation.com

1,054

Full Time Employees

June 30

Fiscal Year Ends

Recent News: 8K7.SI

Performance Overview: 8K7.SI

Trailing total returns as of 6/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

8K7.SI
19.16%
STI Index
1.90%

1-Year Return

8K7.SI
13.46%
STI Index
1.28%

3-Year Return

8K7.SI
77.26%
STI Index
5.21%

5-Year Return

8K7.SI
124.36%
STI Index
2.92%

Compare To: 8K7.SI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8K7.SI

Valuation Measures

Annual
As of 6/14/2024
  • Market Cap

    85.46M

  • Enterprise Value

    68.80M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.90

  • Price/Book (mrq)

    0.50

  • Enterprise Value/Revenue

    0.72

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -22.05%

  • Return on Assets (ttm)

    -6.28%

  • Return on Equity (ttm)

    -12.43%

  • Revenue (ttm)

    94.93M

  • Net Income Avi to Common (ttm)

    -20.93M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    45.13M

  • Total Debt/Equity (mrq)

    16.61%

  • Levered Free Cash Flow (ttm)

    -15.5M

Research Analysis: 8K7.SI

Company Insights: 8K7.SI

Research Reports: 8K7.SI

People Also Watch